Suppr超能文献

低体重老年人的用药过量问题。

Overmedication of the low-weight elderly.

作者信息

Campion E W, Avorn J, Reder V A, Olins N J

出版信息

Arch Intern Med. 1987 May;147(5):945-7.

PMID:3579447
Abstract

This study analyzes age, weight, and drug doses using cimetidine hydrochloride, flurazepam hydrochloride, and digoxin as tracers. Data were obtained for 1797 patients (mean age, 72 years) filling consecutive prescriptions from a national pharmacy service. With all three drugs, patients with lower weight received substantially higher doses with correlations of weight vs dose, based on milligrams per kilogram of body weight, ranging from -0.34 to -0.40. Because body weight declines with increasing age, lower-weight patients are also older and at greatest risk for drug toxicity. Patients weighing 50 kg or less (n = 155) received milligram-per-kilogram doses that were 31% to 46% higher than the group mean and 70% to 88% higher than patients weighing more than 90 kg. For all three study drugs, as patient weight declines, the mean milligram-per-kilogram dose rose sharply. There was no trend seen toward reducing doses for older patients. Low body weight, in addition to advanced age, is a major risk factor for overmedication. Physicians must recognize the need to reduce drug doses for their low-weight elderly patients.

摘要

本研究以盐酸西咪替丁、盐酸氟西泮和地高辛作为示踪剂,分析年龄、体重和药物剂量。数据来自1797名患者(平均年龄72岁),这些患者从一家全国性药房服务机构开具连续处方。对于所有这三种药物,体重较轻的患者每千克体重所接受的剂量要高得多,体重与剂量的相关性(基于每千克体重的毫克数)在-0.34至-0.40之间。由于体重会随着年龄增长而下降,体重较轻的患者年龄也较大,药物毒性风险最高。体重50千克或以下的患者(n = 155)每千克体重的剂量比组均值高31%至46%,比体重超过90千克的患者高70%至88%。对于所有三种研究药物,随着患者体重下降,每千克体重的平均剂量急剧上升。未观察到老年患者有减少剂量的趋势。除高龄外,低体重是用药过量的主要风险因素。医生必须认识到有必要为体重较轻的老年患者减少药物剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验